These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12960603)

  • 1. Interleukin-6, tissue factor and von Willebrand factor in acute decompensated heart failure: relationship to treatment and prognosis.
    Chin BS; Conway DS; Chung NA; Blann AD; Gibbs CR; Lip GY
    Blood Coagul Fibrinolysis; 2003 Sep; 14(6):515-21. PubMed ID: 12960603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of interleukin-6, plasma viscosity, fibrinogen, von Willebrand factor, tissue factor and vascular endothelial growth factor levels in congestive heart failure.
    Chin BS; Blann AD; Gibbs CR; Chung NA; Conway DG; Lip GY
    Eur J Clin Invest; 2003 Nov; 33(11):941-8. PubMed ID: 14636296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of congestive heart failure on plasma von Willebrand factor and soluble P-selectin concentrations in patients with non-valvar atrial fibrillation.
    Lip GY; Pearce LA; Chin BS; Conway DS; Hart RG
    Heart; 2005 Jun; 91(6):759-63. PubMed ID: 15894770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inter-relationships of indices of endothelial damage/dysfunction [circulating endothelial cells, von Willebrand factor and flow-mediated dilatation] to tissue factor and interleukin-6 in acute coronary syndromes.
    Lee KW; Blann AD; Lip GY
    Int J Cardiol; 2006 Aug; 111(2):302-8. PubMed ID: 16324758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma von Willebrand factor and soluble E-selectin levels in stable outpatients with systolic heart failure: the Frederiksberg heart failure study.
    Chong AY; Freestone B; Lim HS; Kistorp C; Gustafsson F; Hildebrandt P; Lip GY
    Int J Cardiol; 2007 Jun; 119(1):80-2. PubMed ID: 17027106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes.
    Chong AY; Freestone B; Patel J; Lim HS; Hughes E; Blann AD; Lip GY
    Am J Cardiol; 2006 Mar; 97(5):671-5. PubMed ID: 16490435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin and von Willebrand factor as parameters of endothelial function in idiopathic dilated cardiomyopathy: different stimuli for release before and after heart transplantation?
    Galatius S; Wroblewski H; Sørensen VB; Bie P; Parving HH; Kastrup J
    Am Heart J; 1999 Mar; 137(3):549-54. PubMed ID: 10047640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired bradykinin response to ischaemia and exercise in patients with mild congestive heart failure during angiotensin-converting enzyme treatment. Relationships with endothelial function, coagulation and inflammation.
    Cugno M; Agostoni P; Mari D; Meroni PL; Gregorini L; Bussotti M; Anguissola GB; Donatelli F; Nussberger J
    Br J Haematol; 2005 Jul; 130(1):113-20. PubMed ID: 15982353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation.
    Cugno M; Mari D; Meroni PL; Gronda E; Vicari F; Frigerio M; Coppola R; Bottasso B; Borghi MO; Gregorini L
    Br J Haematol; 2004 Jul; 126(1):85-92. PubMed ID: 15198737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of acute exercise on hemorheological, endothelial, and platelet markers in patients with chronic heart failure in sinus rhythm.
    Gibbs CR; Blann AD; Edmunds E; Watson RD; Lip GY
    Clin Cardiol; 2001 Nov; 24(11):724-9. PubMed ID: 11714130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory mediators in chronic heart failure in North India.
    Fedacko J; Singh RB; Gupta A; Hristova K; Toda E; Kumar A; Saxena M; Baby A; Singh R; Toru T; Wilson DW
    Acta Cardiol; 2014 Aug; 69(4):391-8. PubMed ID: 25181914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of oral anticoagulant therapy on thrombospondin-1 and von Willebrand factor in patients with stable heart failure.
    Vila V; Sales VM; Almenar L; Lázaro IS; Villa P; Reganon E
    Thromb Res; 2008; 121(5):611-5. PubMed ID: 17692904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with von Willebrand factor and tissue factor.
    Makin AJ; Blann AD; Chung NA; Silverman SH; Lip GY
    Eur Heart J; 2004 Mar; 25(5):371-6. PubMed ID: 15033248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of von Willebrand factor antigen and von Willebrand factor cleaving protease (ADAMTS13) activity predict clinical events in chronic heart failure.
    Gombos T; Makó V; Cervenak L; Papassotiriou J; Kunde J; Hársfalvi J; Förhécz Z; Pozsonyi Z; Borgulya G; Jánoskuti L; Prohászka Z
    Thromb Haemost; 2009 Sep; 102(3):573-80. PubMed ID: 19718479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of atrial fibrillation on plasma von willebrand factor, soluble E-selectin, and N-terminal pro B-type natriuretic peptide levels in systolic heart failure.
    Freestone B; Gustafsson F; Chong AY; Corell P; Kistorp C; Hildebrandt P; Lip GY
    Chest; 2008 May; 133(5):1203-8. PubMed ID: 18339785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial-driven increase in plasma thrombin generation characterising a new hypercoagulable phenotype in acute heart failure.
    Popovic B; Zannad F; Louis H; Clerc-Urmès I; Lakomy C; Gibot S; Denis CV; Lacolley P; Regnault V
    Int J Cardiol; 2019 Jan; 274():195-201. PubMed ID: 30089551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm: effects of angiotensin-converting enzyme inhibitor and beta-blocker therapy.
    Gibbs CR; Blann AD; Watson RD; Lip GY
    Circulation; 2001 Apr; 103(13):1746-51. PubMed ID: 11282905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic venous thrombosis is related to systemic inflammatory response and to increased levels of circulating markers of endothelial dysfunction.
    Jezovnik MK; Poredos P
    Int Angiol; 2010 Jun; 29(3):226-31. PubMed ID: 20502419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Von Willebrand factor (vWF) in patients with heart failure with preserved ejection fraction (HFpEF): A retrospective observational study.
    Abudoukelimu M; Ba B; Kai Guo Y; Xu J
    Medicine (Baltimore); 2022 Aug; 101(31):e29854. PubMed ID: 35945712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neither carvedilol nor bisoprolol in maximally tolerated doses has any specific advantage in lowering chronic heart failure oxidant stress: implications for beta-blocker selection.
    Chin BS; Gibbs CR; Blann AD; Lip GY
    Clin Sci (Lond); 2003 Oct; 105(4):507-12. PubMed ID: 12841846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.